Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • LHochman
    Junior Member
    • Feb 2020
    • 1

    #1

    Calling Data Scientists and Bioinformaticians for the NHLBI Big Data Challenge

    Your computational analysis and machine learning capabilities could help 6.5 million American adults living with heart failure, and you (or your team) could receive an award of up to $50,000 for it.

    The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, announced the “NHLBI Big Data Analysis Challenge: Creating New Paradigms for Heart Failure Research” to foster innovation and address the need for new open-source disease models that can define sub-categorizations of adult heart failure. These models will support new research hypotheses that may lead to further advancements in the management of this disorder.

    Participants are strongly encouraged to take advantage of NHLBI-funded datasets in the development of their Solutions and are also welcome to utilize other relevant data for their analyses.

    The Competition period ends at NOON EDT on August 28, 2020. Learn more at www.nhlbi.nih.gov/HFdatachallenge.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...